Agency Information Collection Request. 60-Day Public Comment Request, 45299-45300 [2017-20738]

Download as PDF Federal Register / Vol. 82, No. 187 / Thursday, September 28, 2017 / Notices 45299 Panels Function Ophthalmic Devices Panel .............. Reviews and evaluates data concerning the safety and effectiveness of marketed and investigational devices for use in the eye and makes appropriate recommendations to the Commissioner of Food and Drugs. II. Qualifications Persons nominated for the device panels should be full-time employees of firms that manufacture products that would come before the panel, or consulting firms that represent manufacturers, or have similar appropriate ties to industry. III. Selection Procedure Any industry organization interested in participating in the selection of an appropriate nonvoting member to represent industry interests should send a letter stating that interest to the FDA contact (see FOR FURTHER INFORMATION CONTACT) within 30 days of publication of this document (see DATES). Within the subsequent 30 days, FDA will send a letter to each organization that has expressed an interest, attaching a complete list of all such organizations; and a list of all nominees along with their current resumes. The letter will also state that it is the responsibility of the interested organizations to confer with one another and to select a candidate, within 60 days after the receipt of the FDA letter, to serve as the nonvoting member to represent industry interests for a particular device panel. The interested organizations are not bound by the list of nominees in selecting a candidate. However, if no individual is selected within 60 days, the Commissioner will select the nonvoting member to represent industry interests. IV. Application Procedure Individuals may self-nominate and/or an organization may nominate one or more individuals to serve as a nonvoting industry representative. Contact information, a current curriculum vitae, and the name of the panel of interest should be sent to the FDA Advisory Committee Membership Nomination Portal (see ADDRESSES) within 30 days of publication of this document (see DATES). FDA will forward all nominations to the organizations expressing interest in participating in the selection process for the particular device panels listed in the table. (Persons who nominate themselves as nonvoting industry representatives will not participate in the selection process). FDA seeks to include the views of women and men, members of all racial and ethnic groups, and individuals with VerDate Sep<11>2014 18:44 Sep 27, 2017 Jkt 241001 and without disabilities on its advisory committees and, therefore encourages nominations of appropriately qualified candidates from these groups. This notice is issued under the Federal Advisory Committee Act (5 U.S.C. app. 2) and 21 CFR part 14, relating to advisory committees. Dated: September 22, 2017. Anna K. Abram, Deputy Commissioner for Policy, Planning, Legislation, and Analysis. [FR Doc. 2017–20778 Filed 9–27–17; 8:45 am] BILLING CODE 4164–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES [Document Identifier: OS–0990–0330] Agency Information Collection Request. 60-Day Public Comment Request Office of the Secretary, HHS. Notice. AGENCY: ACTION: In compliance with the requirement of the Paperwork Reduction Act of 1995, the Office of the Secretary (OS), Department of Health and Human Services, is publishing the following summary of a proposed collection for public comment. DATES: Comments on the ICR must be received on or before November 27, 2017. SUMMARY: Submit your comments to Sherrette.Funn@hhs.gov or by calling (202)795–7714. FOR FURTHER INFORMATION CONTACT: When submitting comments or requesting information, please include the document identifier 0990–0330–60D and project title for reference, to Sherrette.funn@hhs.gov, the Reports Clearance Officer Sherrette Funn, call 202–795–7714. SUPPLEMENTARY INFORMATION: Interested persons are invited to send comments regarding this burden estimate or any other aspect of this collection of information, including any of the following subjects: (1) The necessity and utility of the proposed information collection for the proper performance of the agency’s functions; (2) the accuracy of the estimated burden; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and ADDRESSES: PO 00000 Frm 00044 Fmt 4703 Sfmt 4703 (4) the use of automated collection techniques or other forms of information technology to minimize the information collection burden. Title: Appellant Climate Survey, Revision. Abstract: The Office of Medicare Hearings and Appeals (OMHA) requests revision to a previously approved information collection request from the Office of Management and Budget (OMB). The annual OMHA Appellant Climate Survey is a survey of Medicare beneficiaries, providers, suppliers, or their representatives who participated in a hearing before an Administrative Law Judge (ALJ) from OMHA. Appellants dissatisfied with the outcome of their Level 2 Medicare appeal may request a hearing before an OMHA ALJ. The Appellant Climate Survey will be used to measure appellant satisfaction with their OMHA appeals experience, as opposed to their satisfaction with a specific ruling. OMHA was established by the Medicare Prescription Drug, Improvement, and Modernization Act (MMA) of 2003 (Pub. L. 108–173) and became operational on July 1, 2005. The MMA legislation and implementing regulations issued on March 8, 2007 instituted a number of changes in the appeals process. The MMA legislation also directed HHS to consider the feasibility of conducting hearings using telephone or videoteleconference (VTC) technologies. In carrying out this mandate, OMHA makes use of both teleconferencing and VTC to provide appellants with a vast nationwide network of access points for hearings close to their homes. The first 3-year administration cycle of the OMHA survey began in fiscal year (FY) 2008, a second 3-year cycle began in FY2011, and third 3-year cycle began in FY2014. The survey will continue to be conducted annually over a 3-year period with the next data collection cycle beginning in FY2018. Data collection instruments and recruitment materials will be offered in English and Spanish. Total burden for survey respondents is 100.00 hours each year. Affected Public: Survey respondents will consist of Medicare beneficiaries and non-beneficiaries (i.e., providers, suppliers), who participated in a hearing before an OMHA ALJ. OMHA will draw a representative, nonredundant sample of appellants whose E:\FR\FM\28SEN1.SGM 28SEN1 45300 Federal Register / Vol. 82, No. 187 / Thursday, September 28, 2017 / Notices cases have been closed in the last 6 months. The Committee will meet on October 16, 2017, from 1:00 p.m. to 3:00 p.m. Eastern Time (ET). ADDRESSES: The meeting will be held online via webinar. To register to attend the meeting, please visit the Healthy People Web site at https:// www.healthypeople.gov. DATES: [FR Doc. 2017–20738 Filed 9–27–17; 8:45 am] BILLING CODE 4150–46–P DEPARTMENT OF HEALTH AND HUMAN SERVICES FOR FURTHER INFORMATION CONTACT: Meeting of the Secretary’s Advisory Committee on National Health Promotion and Disease Prevention Objectives for 2030 Office of Disease Prevention and Health Promotion, Office of the Assistant Secretary for Health, Office of the Secretary, Department of Health and Human Services. AGENCY: ACTION: Notice. The U.S. Department of Health and Human Services (HHS) announces the next federal advisory committee meeting regarding the development of national health promotion and disease prevention objectives for 2030. This meeting will be held online via webinar and is open to the public. The Committee will discuss the nation’s health promotion and disease prevention objectives and will provide recommendations to improve health status and reduce health risks for the nation by the year 2030. The Committee will advise the Secretary on the Healthy People 2030 mission, vision, framework, and organizational structure. The Committee will provide advice regarding criteria for identifying a more focused set of measurable, nationally representative objectives. The Committee’s advice must assist the Secretary in reducing the number of objectives while ensuring that the selection criteria identifies the most critical public health issues that are high-impact priorities supported by current national data. SUMMARY: VerDate Sep<11>2014 18:44 Sep 27, 2017 Jkt 241001 Emmeline Ochiai, Designated Federal Official, Secretary’s Advisory Committee on National Health Promotion and Disease Prevention Objectives for 2030, U.S. Department of Health and Human Services, Office of the Assistant Secretary for Health, Office of Disease Prevention and Health Promotion, 1101 Wootton Parkway, Room LL–100, Rockville, MD 20852, (240) 453–8280 (telephone), (240) 453– 8281 (fax). Additional information is available on the Healthy People Web site at https://www.healthypeople.gov. SUPPLEMENTARY INFORMATION: The names and biographies of the Committee members are available at https://www.healthypeople.gov/2020/ about/history-development/healthypeople-2030-advisory-committee. Purpose of Meeting: Through the Healthy People initiative, HHS leverages scientific insights and lessons from the past decade, along with new knowledge of current data, trends, and innovations, to develop the next iteration of national health promotion and disease prevention objectives. Healthy People provides science-based, 10-year national objectives for promoting health and preventing disease. Since 1979, Healthy People has set and monitored national health objectives that meet a broad range of health needs, encourage collaboration across sectors, guide individuals toward making informed health decisions, and measure the impact of our prevention and health promotion activities. Healthy People 2030 health objectives will reflect assessments of major risks to health and wellness, changing public health PO 00000 Frm 00045 Fmt 4703 Sfmt 9990 priorities, and emerging technologies related to our nation’s health preparedness and prevention. Public Participation at Meeting: Members of the public are invited to join the online Committee meeting. There will be no opportunity for oral public comments during this online Committee meeting. However, written comments are welcome throughout the entire development process of the national health promotion and disease prevention objectives for 2030 and may be emailed to HP2030@hhs.gov. To join the Committee meeting, individuals must pre-register at the Healthy People Web site at https:// www.healthypeople.gov. Participation in the meeting is limited. Registrations will be accepted until maximum webinar capacity is reached and must be completed by 9:00 a.m. ET on October 13, 2017. A waiting list will be maintained should registrations exceed capacity and those individuals will be contacted as additional space for the meeting becomes available. Registration questions may be directed to: Kate Fromknecht at fromknecht-kate@ norc.org or (301) 634–9384. Authority: 42 U.S.C. 217a. The Secretary’s Advisory Committee on National Health Promotion and Disease Prevention Objectives for 2030 is governed by provisions of the Federal Advisory Committee Act (FACA), Public Law 92–463, as amended (5 U.S.C., App.) which sets forth standards for the formation and use of federal advisory committees. Dated: September 22, 2017. Don Wright, Deputy Assistant Secretary for Health, (Disease Prevention and Health Promotion). [FR Doc. 2017–20781 Filed 9–27–17; 8:45 am] BILLING CODE 4150–32–P E:\FR\FM\28SEN1.SGM 28SEN1 EN28SE17.003</GPH> Terry S. Clark, Office of the Secretary, Asst. Paperwork Reduction Act Reports Clearance Officer.

Agencies

[Federal Register Volume 82, Number 187 (Thursday, September 28, 2017)]
[Notices]
[Pages 45299-45300]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-20738]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

[Document Identifier: OS-0990-0330]


Agency Information Collection Request. 60-Day Public Comment 
Request

AGENCY: Office of the Secretary, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In compliance with the requirement of the Paperwork Reduction 
Act of 1995, the Office of the Secretary (OS), Department of Health and 
Human Services, is publishing the following summary of a proposed 
collection for public comment.

DATES: Comments on the ICR must be received on or before November 27, 
2017.

ADDRESSES: Submit your comments to Sherrette.Funn@hhs.gov or by calling 
(202)795-7714.

FOR FURTHER INFORMATION CONTACT: When submitting comments or requesting 
information, please include the document identifier 0990-0330-60D and 
project title for reference, to Sherrette.funn@hhs.gov, the Reports 
Clearance Officer Sherrette Funn, call 202-795-7714.

SUPPLEMENTARY INFORMATION: Interested persons are invited to send 
comments regarding this burden estimate or any other aspect of this 
collection of information, including any of the following subjects: (1) 
The necessity and utility of the proposed information collection for 
the proper performance of the agency's functions; (2) the accuracy of 
the estimated burden; (3) ways to enhance the quality, utility, and 
clarity of the information to be collected; and (4) the use of 
automated collection techniques or other forms of information 
technology to minimize the information collection burden.
    Title: Appellant Climate Survey, Revision.
    Abstract: The Office of Medicare Hearings and Appeals (OMHA) 
requests revision to a previously approved information collection 
request from the Office of Management and Budget (OMB). The annual OMHA 
Appellant Climate Survey is a survey of Medicare beneficiaries, 
providers, suppliers, or their representatives who participated in a 
hearing before an Administrative Law Judge (ALJ) from OMHA. Appellants 
dissatisfied with the outcome of their Level 2 Medicare appeal may 
request a hearing before an OMHA ALJ. The Appellant Climate Survey will 
be used to measure appellant satisfaction with their OMHA appeals 
experience, as opposed to their satisfaction with a specific ruling. 
OMHA was established by the Medicare Prescription Drug, Improvement, 
and Modernization Act (MMA) of 2003 (Pub. L. 108-173) and became 
operational on July 1, 2005. The MMA legislation and implementing 
regulations issued on March 8, 2007 instituted a number of changes in 
the appeals process. The MMA legislation also directed HHS to consider 
the feasibility of conducting hearings using telephone or video-
teleconference (VTC) technologies. In carrying out this mandate, OMHA 
makes use of both teleconferencing and VTC to provide appellants with a 
vast nationwide network of access points for hearings close to their 
homes. The first 3-year administration cycle of the OMHA survey began 
in fiscal year (FY) 2008, a second 3-year cycle began in FY2011, and 
third 3-year cycle began in FY2014. The survey will continue to be 
conducted annually over a 3-year period with the next data collection 
cycle beginning in FY2018. Data collection instruments and recruitment 
materials will be offered in English and Spanish. Total burden for 
survey respondents is 100.00 hours each year.
    Affected Public: Survey respondents will consist of Medicare 
beneficiaries and non-beneficiaries (i.e., providers, suppliers), who 
participated in a hearing before an OMHA ALJ. OMHA will draw a 
representative, non-redundant sample of appellants whose

[[Page 45300]]

cases have been closed in the last 6 months.
[GRAPHIC] [TIFF OMITTED] TN28SE17.003


Terry S. Clark,
Office of the Secretary, Asst. Paperwork Reduction Act Reports 
Clearance Officer.
[FR Doc. 2017-20738 Filed 9-27-17; 8:45 am]
 BILLING CODE 4150-46-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.